July 9, 2007 – Jiangsu Hansen Pharmaceutical Co. Ltd, known as Hansenpharm Co., has started to sell its generic version of Zyprexa, an anti-psychotic used widely to treat schizophrenia that is a billion-dollar seller for Lilly. In late 2006, Hansenpharm won a five-year-long Chinese patent suit over the drug and its method of production. It was the first time a Chinese company prevailed in an infringement lawsuit against a major international biopharma. Hansenpharm introduced the drug at a price that was half the cost of the Lilly version. More details...